Key result
Aggressive treatment for statin-induced necrotizing autoimmune myopathy yielded limited recovery, highlighting therapeutic uncertainty and a lack of standardized guidelines.
Population
A patient with Statin-induced necrotizing autoimmune myopathy (SINAM)
Design
Case_report
Authors
Loading...
May warrant cautious immunosuppression in SINAM; leaves open standardized protocols and prospective trials.
This case report highlights the therapeutic uncertainty and limited recovery associated with statin-induced necrotizing autoimmune myopathy despite aggressive treatment.
Chacón et al. (2026) studied this question. Aggressive treatment for statin-induced necrotizing autoimmune myopathy yielded limited recovery, highlighting therapeutic uncertainty and a lack of standardized guidelines.